Rofiplag

Rofiplag composition

• Tirofiban 5mg/100 ml

• Tirofiban 10mg/150 ml

• Tirofiban 20 mg/200 ml

• None of the the correct

Which USPs is not the correct for Rofiplag

• Bottle Hanger

• Thermocol packing for the protection from moisture

• Thermocol packing with protection from light

• Type 1 flint glass bottle

• Better chemical resistance

Which is not the right Indication for Rofiplag

• Acute coronary syndrome

• Undergoing PTCA

• Atherectomy

• Myocardial infarction

Rofilag MOA

• GP IIb/IIIa inhibitors bind to the receptor and prevent fibrinogen

• GP IIb/IIIa inhibitors bind to the receptor and prevent fibrinogen from binding to the receptors which inhibits platelet aggregation

• GP IIb2/IIIa3 inhibitors bind to the receptor and prevent fibrinogen from binding to the receptors which inhibits platelet aggregation

• GP IIa inhibitors bind to the receptor and prevent fibrinogen from binding to the receptors which inhibits platelet aggregation

Which is not the correct brand Molecule USPs of Rofiplag

• •Highly specific for the GP IIb/IIIa receptor

• •Less thrombocytopenia than others.

• •Can be given in High dose

• •Recommended by guidelines

• Delayed •onset of action

Which is not the Brand USPs of Rofiplag

• Attractive thermacol packing

• High MRP

• Tinted glass technology

• Packing is not attractive